Cancer Risk Forces Recall of Weight-Loss Drug Belviq

Bookmark
(Bloomberg) -- Weight-loss drug Belviq will be withdrawn from the U.S. market at the request of the Food and Drug Administration, after research tied it to increased rates of cancer.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.